Orforglipron had a similar safety profile as other GLP-1 receptor agonists. Trial outcomes For ATTAIN-2, researchers enrolled 1,613 adults aged 18 years and older with obesity or overweight plus one weight-related comorbidity, and with type 2 diabetes with an HbA1c between 7% and 10% at baseline (mean age, 56.8 years
Because the preclinical literature on each individually points at overlapping wound-repair pathways, and a single vial is operationally simpler for research that wants to compare a co-administered condition to a single-peptide condition
Reduction of TRT needs: Some men on testosterone replacement therapy (TRT) can reduce doses or discontinue entirely as natural production recovers with weight loss
That is worth repeating
The thigh is one of three preferred injection zones, offering convenience and accessibility for weekly self-administration
In Q1 2024, Hims & Hers attracted a record 172,000 subscribers